Levobupivacaïne Molteni

Levobupivacaine, the active ingredient in Levobupivacaïne Molteni, is a local anesthetic (amide) presented as a sterile solution for epidural, infiltration and intrathecal use. It provides reversible nerve block for surgical anesthesia, epidural analgesia, post‑operative pain control and obstetric analgesia. GNH USA supplies Levobupivacaïne Molteni as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levobupivacaine is a long‑acting amide local anesthetic used in several procedural settings. - Surgical anesthesia: produces dense sensory and motor block for operative procedures. - Epidural analgesia: provides continuous pain relief during labor or postoperative periods. - Post‑operative pain control: extends analgesia after surgery when administered via wound infiltration. - Obstetric analgesia: facilitates pain management during childbirth while preserving maternal motor function.

Levobupivacaine, like other amide local anesthetics, may cause a range of adverse reactions.

Common Side Effects: - Tingling or numbness at the injection site - Transient hypotension - Mild dizziness or light‑headedness - Nausea or vomiting - Pruritus or mild skin rash

Serious or Rare Side Effects: - Cardiovascular collapse or arrhythmia - Central nervous system toxicity (seizures, respiratory depression) - Methemoglobinemia - Allergic anaphylaxis - Persistent motor block beyond expected duration

Levobupivacaine should be used with careful patient assessment and monitoring. - Dose selection: follow prescriber’s recommendation based on patient weight, age and procedure. - Cardiac monitoring: observe for signs of arrhythmia or hypotension during and after administration. - Neurological assessment: watch for prolonged sensory or motor block, especially in high‑risk patients. - Contraindications: avoid in patients with known hypersensitivity to amide local anesthetics. - Drug interactions: review concomitant medications that may affect cardiac or CNS function. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Levobupivacaine may interact with other agents that influence cardiac conduction or central nervous system activity.

Major Interactions (Avoid): - Class I anti‑arrhythmic drugs (e.g., quinidine, procainamide) – additive cardiotoxicity. - Potent CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) – may increase plasma levels.

Moderate Interactions (Monitor Closely): - Other local anesthetics – risk of cumulative toxicity. - Central nervous system depressants (e.g., benzodiazepines, opioids) – enhanced sedation or respiratory depression. - Beta‑blockers – may potentiate bradycardia when combined with high doses.